tiprankstipranks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market

Arcus Biosciences (RCUS) Financial Statements

Compare
477 Followers

Arcus Biosciences Financial Overview

Arcus Biosciences's market cap is currently $816.04M. The company's EPS TTM is $-3.098; its P/E ratio is ―; Arcus Biosciences is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-1.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 258.00M$ 117.00M$ 112.00M$ 382.88M$ 77.52M
Gross Profit$ 258.00M$ -223.00M$ 98.00M$ 375.82M$ -81.48M
Operating Income$ -330.00M$ -340.00M$ -280.00M$ 54.25M$ -124.23M
EBITDA$ -269.00M$ -283.00M$ -250.00M$ 61.96M$ -118.47M
Net Income$ -283.00M$ -307.00M$ -267.00M$ 53.00M$ -116.68M
Balance Sheet
Cash & Short-Term Investments$ 978.00M$ 759.00M$ 1.14B$ 681.30M$ 735.09M
Total Assets$ 1.15B$ 1.09B$ 1.34B$ 1.59B$ 772.29M
Total Debt$ 48.00M$ 11.00M$ 120.00M$ 116.89M$ 15.24M
Net Debt$ -102.00M$ -116.00M$ -86.00M$ -31.03M$ -158.17M
Total Liabilities$ 665.00M$ 633.00M$ 688.00M$ 750.45M$ 269.99M
Stockholders' Equity$ 485.00M$ 462.00M$ 657.00M$ 841.45M$ 502.30M
Cash Flow
Free Cash Flow$ -176.00M$ -330.00M$ 426.00M$ -282.25M$ 108.11M
Operating Cash Flow$ -170.00M$ -306.00M$ 438.00M$ -256.17M$ 111.17M
Investing Cash Flow$ -84.00M$ 194.00M$ -413.00M$ -3.87M$ -434.37M
Financing Cash Flow$ 277.00M$ 33.00M$ 33.00M$ 237.34M$ 438.68M
Currency in USD

Arcus Biosciences Earnings and Revenue History

Arcus Biosciences Debt to Assets

Arcus Biosciences Cash Flow

Arcus Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis